Guangdong Taienkang Pharmaceutical Co., Ltd. Stock: price and insider trades · China
泰恩康
No insider purchase over the last 90 days. The latest, by 李挺, was filed 06 Jun 2024.
Guangdong Taienkang Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of Guangdong Taienkang Pharmaceutical Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Guangdong Taienkang Pharmaceutical Co., Ltd. in twelve months, the latest record being from 6 June 2024.
Since 2022, the database holds 13 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- +171.7%Entry CN¥12.99 · Close at T+365 CN¥35.30
- -7.2%Entry CN¥16.16 · Close at T+365 CN¥15.00
- -6.6%Entry CN¥16.95 · Close at T+365 CN¥15.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 45,400 shares8.1% of flowA股XSHESZSE:173000007730901060Canonical exit: 4 Sept 2024 (T+90)
- 55,500 shares10.5% of flowA股XSHESZSE:173000007543776300Canonical exit: 23 Jul 2024 (T+90)
- 17,200 shares3.5% of flowA股XSHESZSE:173000007280271420Canonical exit: 24 Apr 2024 (T+90)
- 34,900 shares7.2% of flowA股XSHESZSE:173000007264441600Canonical exit: 17 Apr 2024 (T+90)
- 20,000 shares4.4% of flowA股XSHESZSE:173000007254324200Canonical exit: 11 Apr 2024 (T+90)
- 59,300 shares13.0% of flowA股XSHESZSE:173000007195789950Canonical exit: 27 Mar 2024 (T+90)
- 17,500 shares11.3% of flowA股XSHESZSE:173000007186551870Canonical exit: 24 Mar 2024 (T+90)
- 20,500 shares13.5% of flowA股XSHESZSE:173000007184914020Canonical exit: 21 Mar 2024 (T+90)
- 63,400 shares54.9% of flowA股XSHESZSE:173000007178916300Canonical exit: 19 Mar 2024 (T+90)
- 50,000 shares45.1% of flowA股XSHESZSE:173000007150920700Canonical exit: 4 Mar 2024 (T+90)
- 200,000 shares53.4% of flowA股XSHESZSE:173000006875562400Canonical exit: 27 Nov 2023 (T+90)
- 100,900 shares75.2% of flowA股XSHESZSE:173000006875562300Canonical exit: 27 Nov 2023 (T+90)
- 4,000 shares100.0% of flowA股XSHESZSE:173000005697145820Canonical exit: 16 Oct 2022 (T+90)
13 of 13 declarations
About Guangdong Taienkang Pharmaceutical Co., Ltd.
泰恩康 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It specializes in the development and marketing of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
